GO
Loading...

Health Care Supplies

More

  • NEW YORK, Oct 13- Shares of little-known medical equipment and biotech companies jumped on Wall Street on Monday, after news that a nurse had become the first person to contract the deadly Ebola virus in the United States. Shares of biotechnology company Ibio Inc, hazmat suits maker Lakeland Industries Inc, and face mask maker Alpha Pro Tech Ltd all ended the day...

  • NEW YORK, Oct 13- Little-known medical equipment and biotech companies jumped on Wall Street on Monday, following news that a nurse had become the first person to contract the deadly Ebola virus in the United States. Shares of biotechnology company Ibio Inc, hazmat suits maker Lakeland Industries Inc, and face mask maker Alpha Pro Tech Ltd were all higher near...

  • Oct 5- Medical equipment supplier Becton Dickinson& Co has agreed to buy CareFusion Corp, a maker of infusion pumps and other medical devices, for $12.2 billion in cash and stock, marking the latest multibillion-dollar healthcare sector deal. Becton said on Sunday it would pay a total of $58.00 a share- $49.00 in cash and 0.0777 of a share of Becton Dickinson- for...

  • Gadgets for the road: Best of the new travel tech Saturday, 27 Sep 2014 | 11:00 AM ET

    There are new inventions out there to solve some of the oldest problems for business travelers.

  • Ebola panic may give these stocks a fillip Wednesday, 13 Aug 2014 | 6:35 PM ET

    Shares of Malaysia's latex glove makers have had a tough year so far, but some analysts expect panic over Africa's Ebola outbreak may spur gains.

  • July 24- Boston Scientific Corp, which makes medical equipment, on Thursday reported a slightly higher-than-expected quarterly profit as improvements in its heart device business helped drive revenue up 4 percent.

  • Will ghoulish investments pay off? Monday, 16 Jun 2014 | 6:57 PM ET
    Elderly women wait for lunch to be served at a day care facility on Gogo Island in Matsuyama, Ehime Prefecture, Japan

    As the global population ages, some see investment opportunities in somewhat ghoulish bets the rates of cancer and other illnesses will rise.

  • Shire braces for takeover bids, hires Citi: Sources Monday, 16 Jun 2014 | 2:25 PM ET
    Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc.

    Shire has hired investment bank Citi as an adviser following a wave of deals in the healthcare sector.

  • J&J beats forecasts, helped by new medicines Tuesday, 15 Apr 2014 | 10:06 AM ET

    Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.

  • Diabetic entrepreneur sells to growing population Monday, 7 Apr 2014 | 1:12 PM ET

    Profile of 27-year-old Ethan Lewis, who has been creating products to sell to his fellow diabetics.

  • Got migraines? The FDA has a headband for you Tuesday, 11 Mar 2014 | 4:41 PM ET

    The Cefaly device uses a mild electric current to prevent migraines.

  • Smile! Here's the next 'smart' product Thursday, 20 Feb 2014 | 10:00 AM ET

    P&G is bringing the dentist into your bathroom a smartphone-connected toothbrush, a device that gives personalized advice to help people improve their brushing.

  • JNJ to pay $2.2 billion in US probe: Feds Monday, 4 Nov 2013 | 1:53 PM ET

    Johnson & Johnson and its subsidiaries were accused of promoting powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

  • Lacks family wins victory to claim woman's cells Thursday, 8 Aug 2013 | 8:12 AM ET
    Multiphoton fluorescence image of cultured HeLa cells with a fluorescent protein targeted to the Golgi apparatus (orange), microtubules (green) and counterstained for DNA (cyan).

    The family of Henrietta lacks, whose immortal cells made billions in medical research, won an ethical victory when they were given some power over HeLa cell information.

  • Henry Schein's healthy results  Tuesday, 6 Aug 2013 | 2:48 PM ET

    Henry Schein is the world's largest health care products and services company for doctors, dentists, and vets, and the stock has been on a tear. Stanley Bergman, Henry Schein chairman and CEO, shares where he sees dental and health care headed.

  • J&J beats expectations as drugs, devices deliver Tuesday, 16 Jul 2013 | 7:50 AM ET

    Johnson & Johnson reported higher-than-expected earnings as strong sales of prescription drugs and medical devices more than offset anemic growth of its consumer products.

  • Plan-B for All—No Age Limits on Morning-After Pill Tuesday, 11 Jun 2013 | 10:17 AM ET

    Obama administration to scrap age restrictions on the sale of morning-after pills, making the emergency contraception available to women and girls of any age without a prescription.

  • Bristol and Merck Shares Surge on Cancer Drug News Monday, 3 Jun 2013 | 3:32 PM ET

    Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.

  • Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.

  • Johnson & Johnson's Stock Looks Too Healthy Wednesday, 1 May 2013 | 3:02 PM ET

    Johnson & Johnson's stock has gained 22 percent on the year and trades at a higher P/E ratio than its competitors. It is not a good buy now, but a great hold, TheStreet.com says.